Mylan Bolsters Global Injectables Business with Deal to Acquire Agila Specialities from Strides Arcolab
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 3 (Table of Contents)
Published: 12 Mar-2013
DOI: 10.3833/pdr.v2013.i3.1909 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Putting an end to speculation about the future of the division, India’s Strides Arcolab has agreed to divest its generic injectables unit Agila Specialities to Mylan for US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS